IP Library Granted Patent US 9,404,158
Granted Patent B2
US 9,404,158 · App. 13/030,485 · Granted Aug 2, 2016

Alternative splicing variant of OATP1B3 mRNA

Inventors: Tomomi Furihata (Chiba, JP); Sayaka Matsumoto (Chiba, JP); Miki Nagai (Chiba, JP); Kan Chiba (Chiba, JP)
Assignee: National University Corporation Chiba University
C12Q1/6886C07K14/4748G01N33/5011A61K39/00C07K2319/21C07K2319/41C07K2319/42C07K2319/43C07K2319/60C12Q2600/136C12Q2600/156C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,404,158
App. No.
13/030,485
Filed
Feb 18, 2011
Granted
Aug 2, 2016
Kind
B2
Art Unit
1682
USPC
435/6
Abstract

[PROBLEM TO BE SOLVED] An object of the present invention is to provide a novel tumor marker and use thereof. In more detail, the present invention provides a novel tumor marker, a method for measuring said tumor marker and a measurement kit, a method for detecting cancer using the same, a kit for detecting cancer, a method for screening a preventive and/or therapeutic agent for cancer, as well as a medicament such as cancer vaccine. [SOLUTION] According to the present invention, a method for measuring an alternative splicing variant of OATP1B3 mRNA in a sample to be examined is provided. Said measurement method comprises measuring mRNA comprising a nucleotide sequence represented by SEQ ID NO: 1 in the sequence listing table in a sample to be examined isolated from living organism with differentiation from a mRNA comprising a nucleotide sequence represented by SEQ ID NO: 2. Said measurement method is useful for detecting cancer or screening a preventive and/or therapeutic agent.

Claims (6)

1. An isolated deoxyribonucleic acid satisfying the following conditions:

(1) the isolated deoxyribonucleic acid is capable of hybridizing to a nucleic acid comprising the nucleotide sequence of SEQ ID NO: 1 under a stringent condition;

(2) the isolated deoxyribonucleic acid does not hybridize to a nucleic acid comprising the nucleotide sequence of SEQ ID NO: 2 under the stringent condition or all but its 3′ terminus hybridizes to the nucleic acid comprising the nucleotide sequence of SEQ ID NO: 2 under the stringent condition; and

(3) 20% to 80% of the length of the isolated deoxyribonucleic acid hybridizes to exon SV in SEQ ID NO: 1 under the stringent condition and the length of the isolated deoxyribonucleic acid that does not hybridize to exon SV under the stringent condition hybridizes to exon 3 of SEQ ID NO: 1 under the stringent condition, wherein the isolated deoxyribonucleic acid includes a fluorescent label, a biotin label, a radioactive label, or an enzyme label and is 25 to 35 nucleotides in length.

2. A kit for measuring an alternative splicing variant of OATP1B3 mRNA, comprising the isolated deoxyribonucleic acid according to claim 1 .

3. An isolated deoxyribonucleic acid having the nucleotide sequence of SEQ ID NO: 1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2011
From: FURIHATA, TOMOMI; MATSUMOTO, SAYAKA; NAGAI, MIKI; CHIBA, KAN
To: NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
Reel/Frame 026679/0834 →
Priority Claims (2)
JP 2010-035166 · Feb 19, 2010 · national
JP 2011-032501 · Feb 17, 2011 · national
Continuity (1)
Related Publication 20120014977A1 · Jan 19, 2012